Details for New Drug Application (NDA): 205186
✉ Email this page to a colleague
The generic ingredient in ELETRIPTAN HYDROBROMIDE is eletriptan hydrobromide. There are twelve drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the eletriptan hydrobromide profile page.
Summary for 205186
Tradename: | ELETRIPTAN HYDROBROMIDE |
Applicant: | Ajanta Pharma Ltd |
Ingredient: | eletriptan hydrobromide |
Patents: | 0 |
Pharmacology for NDA: 205186
Mechanism of Action | Serotonin 1b Receptor Agonists Serotonin 1d Receptor Agonists |
Suppliers and Packaging for NDA: 205186
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ELETRIPTAN HYDROBROMIDE | eletriptan hydrobromide | TABLET;ORAL | 205186 | ANDA | Ajanta Pharma USA Inc. | 27241-039 | 27241-039-11 | 1 BLISTER PACK in 1 CARTON (27241-039-11) / 6 TABLET, FILM COATED in 1 BLISTER PACK (27241-039-68) |
ELETRIPTAN HYDROBROMIDE | eletriptan hydrobromide | TABLET;ORAL | 205186 | ANDA | Ajanta Pharma USA Inc. | 27241-040 | 27241-040-11 | 1 BLISTER PACK in 1 CARTON (27241-040-11) / 6 TABLET, FILM COATED in 1 BLISTER PACK (27241-040-68) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 20MG BASE | ||||
Approval Date: | Aug 29, 2017 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 40MG BASE | ||||
Approval Date: | Aug 29, 2017 | TE: | AB | RLD: | No |
Complete Access Available with Subscription